Idelalisib Terminated Phase 2 Trials for Small Lymphocytic Lymphoma (SLL) / Chronic Lymphocytic Leukaemia (CLL) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01203930A Study of Idelalisib and Rituximab in Elderly Patients With Untreated CLL or SLL